----
Current ValuationThe current P/E ratio is 14.82, within the reasonable range, cheaper than 20.38% of the time in the past 1 years, and the industry ranks 9/54, the industry Median -0.25.
14.82xP/E
$6.00Stock price
$0.40Earnings per share
14.82xP/E
Stock price$6.00Earnings per share$0.40
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 9.27x
- Typical range
- 7.78x–14.82x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
04998147196
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
ULUSUnilever | 12.61x | 17.90% | $135.77B |
BDRFYUSBeiersdorf | 17.57x | -- | $19.14B |
NATRUSNatures Sunshine | 12.29x | 0.47% | $222.41M |
NAGEUSNiagen Bioscience | 13.31x | 33.00% | $212.85M |
FTLFUSFitLife Brands | 13.88x | 37.30% | $86.49M |
LFVNUSLifevantage | 14.82x | 51.25% | $75.16M |
AXILUSAXIL Brands | 13.98x | 112.12% | $38.96M |
UGUSUnited-Guardian | 13.04x | -- | $32.16M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
